Psoriasis Drugs market worldwide is projected to grow by US$10. 8 Billion, driven by a compounded growth of 9%. Tumor Necrosis Factor Inhibitor, one of the segments analyzed and sized in this study, displays the potential to grow at over 9%.

New York, Oct. 11, 2019 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Psoriasis Drugs Industry" - https://www.reportlinker.com/p05818016/?utm_source=GNW
The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$8.1 Billion by the year 2025, Tumor Necrosis Factor Inhibitor will bring in healthy gains adding significant momentum to global growth.

- Representing the developed world, the United States will maintain a 7.6% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$367.7 Million to the region’s size and clout in the next 5 to 6 years. Over US$321.2 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, Tumor Necrosis Factor Inhibitor will reach a market size of US$377.2 Million by the close of the analysis period. As the world’s second largest economy and the new game changer in global markets, China exhibits the potential to grow at 13.2% over the next couple of years and add approximately US$3.1 Billion in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

- Competitors identified in this market include among others, AbbVie, Inc.; Amgen, Inc.; Celgene Corporation; Eli Lilly and Company; Johnson & Johnson; Merck & Co., Inc.; Novartis International AG; UCB SA


Read the full report: https://www.reportlinker.com/p05818016/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Global Competitor Market Shares
Psoriasis Drugs Competitor Market Share Scenario Worldwide
(in %): 2019 & 2028
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
Table 1: Psoriasis Drugs Global Market Estimates and Forecasts
in US$ Million by Region/Country: 2018-2025
Table 2: Psoriasis Drugs Global Retrospective Market Scenario
in US$ Million by Region/Country: 2009-2017
Table 3: Psoriasis Drugs Market Share Shift across Key
Geographies Worldwide: 2009 VS 2019 VS 2025
Table 4: Tumor Necrosis Factor Inhibitor (Therapeutic Class)
World Market by Region/Country in US$ Million: 2018 to 2025
Table 5: Tumor Necrosis Factor Inhibitor (Therapeutic Class)
Historic Market Analysis by Region/Country in US$ Million: 2009
to 2017
Table 6: Tumor Necrosis Factor Inhibitor (Therapeutic Class)
Market Share Breakdown of Worldwide Sales by Region/Country:
2009 VS 2019 VS 2025
Table 7: Interleukin Inhibitors (Therapeutic Class) Potential
Growth Markets Worldwide in US$ Million: 2018 to 2025
Table 8: Interleukin Inhibitors (Therapeutic Class) Historic
Market Perspective by Region/Country in US$ Million: 2009 to
2017
Table 9: Interleukin Inhibitors (Therapeutic Class) Market
Sales Breakdown by Region/Country in Percentage: 2009 VS 2019
VS 2025
Table 10: Other Therapeutic Classes (Therapeutic Class)
Geographic Market Spread Worldwide in US$ Million: 2018 to 2025
Table 11: Other Therapeutic Classes (Therapeutic Class) Region
Wise Breakdown of Global Historic Demand in US$ Million: 2009
to 2017
Table 12: Other Therapeutic Classes (Therapeutic Class) Market
Share Distribution in Percentage by Region/Country: 2009 VS
2019 VS 2025
Table 13: Topicals (Treatment) World Market Estimates and
Forecasts by Region/Country in US$ Million: 2018 to 2025
Table 14: Topicals (Treatment) Market Historic Review by
Region/Country in US$ Million: 2009 to 2017
Table 15: Topicals (Treatment) Market Share Breakdown by
Region/Country: 2009 VS 2019 VS 2025
Table 16: Systemic (Treatment) World Market by Region/Country
in US$ Million: 2018 to 2025
Table 17: Systemic (Treatment) Historic Market Analysis by
Region/Country in US$ Million: 2009 to 2017
Table 18: Systemic (Treatment) Market Share Distribution in
Percentage by Region/Country: 2009 VS 2019 VS 2025
Table 19: Biologics (Treatment) World Market Estimates and
Forecasts in US$ Million by Region/Country: 2018 to 2025
Table 20: Biologics (Treatment) Market Worldwide Historic
Review by Region/Country in US$ Million: 2009 to 2017
Table 21: Biologics (Treatment) Market Percentage Share
Distribution by Region/Country: 2009 VS 2019 VS 2025

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS
UNITED STATES
Market Facts & Figures
US Psoriasis Drugs Market Share (in %) by Company: 2019 & 2025
Table 22: United States Psoriasis Drugs Market Estimates and
Projections in US$ Million by Therapeutic Class: 2018 to 2025
Table 23: Psoriasis Drugs Market in the United States by
Therapeutic Class: A Historic Review in US$ Million for
2009-2017
Table 24: United States Psoriasis Drugs Market Share Breakdown
by Therapeutic Class: 2009 VS 2019 VS 2025
Table 25: United States Psoriasis Drugs Market Estimates and
Projections in US$ Million by Treatment: 2018 to 2025
Table 26: Psoriasis Drugs Market in the United States by
Treatment: A Historic Review in US$ Million for 2009-2017
Table 27: United States Psoriasis Drugs Market Share Breakdown
by Treatment: 2009 VS 2019 VS 2025
CANADA
Table 28: Canadian Psoriasis Drugs Market Estimates and
Forecasts in US$ Million by Therapeutic Class: 2018 to 2025
Table 29: Canadian Psoriasis Drugs Historic Market Review by
Therapeutic Class in US$ Million: 2009-2017
Table 30: Psoriasis Drugs Market in Canada: Percentage Share
Breakdown of Sales by Therapeutic Class for 2009, 2019, and
2025
Table 31: Canadian Psoriasis Drugs Market Estimates and
Forecasts in US$ Million by Treatment: 2018 to 2025
Table 32: Canadian Psoriasis Drugs Historic Market Review by
Treatment in US$ Million: 2009-2017
Table 33: Psoriasis Drugs Market in Canada: Percentage Share
Breakdown of Sales by Treatment for 2009, 2019, and 2025
JAPAN
Table 34: Japanese Market for Psoriasis Drugs: Annual Sales
Estimates and Projections in US$ Million by Therapeutic Class
for the Period 2018-2025
Table 35: Psoriasis Drugs Market in Japan: Historic Sales
Analysis in US$ Million by Therapeutic Class for the Period
2009-2017
Table 36: Japanese Psoriasis Drugs Market Share Analysis by
Therapeutic Class: 2009 VS 2019 VS 2025
Table 37: Japanese Market for Psoriasis Drugs: Annual Sales
Estimates and Projections in US$ Million by Treatment for the
Period 2018-2025
Table 38: Psoriasis Drugs Market in Japan: Historic Sales
Analysis in US$ Million by Treatment for the Period 2009-2017
Table 39: Japanese Psoriasis Drugs Market Share Analysis by
Treatment: 2009 VS 2019 VS 2025
CHINA
Table 40: Chinese Psoriasis Drugs Market Growth Prospects in
US$ Million by Therapeutic Class for the Period 2018-2025
Table 41: Psoriasis Drugs Historic Market Analysis in China in
US$ Million by Therapeutic Class: 2009-2017
Table 42: Chinese Psoriasis Drugs Market by Therapeutic Class:
Percentage Breakdown of Sales for 2009, 2019, and 2025
Table 43: Chinese Psoriasis Drugs Market Growth Prospects in
US$ Million by Treatment for the Period 2018-2025
Table 44: Psoriasis Drugs Historic Market Analysis in China in
US$ Million by Treatment: 2009-2017
Table 45: Chinese Psoriasis Drugs Market by Treatment:
Percentage Breakdown of Sales for 2009, 2019, and 2025
EUROPE
Market Facts & Figures
European Psoriasis Drugs Market: Competitor Market Share
Scenario (in %) for 2019 & 2025
Table 46: European Psoriasis Drugs Market Demand Scenario in
US$ Million by Region/Country: 2018-2025
Table 47: Psoriasis Drugs Market in Europe: A Historic Market
Perspective in US$ Million by Region/Country for the Period
2009-2017
Table 48: European Psoriasis Drugs Market Share Shift by
Region/Country: 2009 VS 2019 VS 2025
Table 49: European Psoriasis Drugs Market Estimates and
Forecasts in US$ Million by Therapeutic Class: 2018-2025
Table 50: Psoriasis Drugs Market in Europe in US$ Million by
Therapeutic Class: A Historic Review for the Period 2009-2017
Table 51: European Psoriasis Drugs Market Share Breakdown by
Therapeutic Class: 2009 VS 2019 VS 2025
Table 52: European Psoriasis Drugs Market Estimates and
Forecasts in US$ Million by Treatment: 2018-2025
Table 53: Psoriasis Drugs Market in Europe in US$ Million by
Treatment: A Historic Review for the Period 2009-2017
Table 54: European Psoriasis Drugs Market Share Breakdown by
Treatment: 2009 VS 2019 VS 2025
FRANCE
Table 55: Psoriasis Drugs Market in France by Therapeutic
Class: Estimates and Projections in US$ Million for the Period
2018-2025
Table 56: French Psoriasis Drugs Historic Market Scenario in
US$ Million by Therapeutic Class: 2009-2017
Table 57: French Psoriasis Drugs Market Share Analysis by
Therapeutic Class: 2009 VS 2019 VS 2025
Table 58: Psoriasis Drugs Market in France by Treatment:
Estimates and Projections in US$ Million for the Period
2018-2025
Table 59: French Psoriasis Drugs Historic Market Scenario in
US$ Million by Treatment: 2009-2017
Table 60: French Psoriasis Drugs Market Share Analysis by
Treatment: 2009 VS 2019 VS 2025
GERMANY
Table 61: Psoriasis Drugs Market in Germany: Recent Past,
Current and Future Analysis in US$ Million by Therapeutic Class
for the Period 2018-2025
Table 62: German Psoriasis Drugs Historic Market Analysis in
US$ Million by Therapeutic Class: 2009-2017
Table 63: German Psoriasis Drugs Market Share Breakdown by
Therapeutic Class: 2009 VS 2019 VS 2025
Table 64: Psoriasis Drugs Market in Germany: Recent Past,
Current and Future Analysis in US$ Million by Treatment for the
Period 2018-2025
Table 65: German Psoriasis Drugs Historic Market Analysis in
US$ Million by Treatment: 2009-2017
Table 66: German Psoriasis Drugs Market Share Breakdown by
Treatment: 2009 VS 2019 VS 2025
ITALY
Table 67: Italian Psoriasis Drugs Market Growth Prospects in
US$ Million by Therapeutic Class for the Period 2018-2025
Table 68: Psoriasis Drugs Historic Market Analysis in Italy in
US$ Million by Therapeutic Class: 2009-2017
Table 69: Italian Psoriasis Drugs Market by Therapeutic Class:
Percentage Breakdown of Sales for 2009, 2019, and 2025
Table 70: Italian Psoriasis Drugs Market Growth Prospects in
US$ Million by Treatment for the Period 2018-2025
Table 71: Psoriasis Drugs Historic Market Analysis in Italy in
US$ Million by Treatment: 2009-2017
Table 72: Italian Psoriasis Drugs Market by Treatment:
Percentage Breakdown of Sales for 2009, 2019, and 2025
UNITED KINGDOM
Table 73: United Kingdom Market for Psoriasis Drugs: Annual
Sales Estimates and Projections in US$ Million by Therapeutic
Class for the Period 2018-2025
Table 74: Psoriasis Drugs Market in the United Kingdom:
Historic Sales Analysis in US$ Million by Therapeutic Class for
the Period 2009-2017
Table 75: United Kingdom Psoriasis Drugs Market Share Analysis
by Therapeutic Class: 2009 VS 2019 VS 2025
Table 76: United Kingdom Market for Psoriasis Drugs: Annual
Sales Estimates and Projections in US$ Million by Treatment for
the Period 2018-2025
Table 77: Psoriasis Drugs Market in the United Kingdom:
Historic Sales Analysis in US$ Million by Treatment for the
Period 2009-2017
Table 78: United Kingdom Psoriasis Drugs Market Share Analysis
by Treatment: 2009 VS 2019 VS 2025
SPAIN
Table 79: Spanish Psoriasis Drugs Market Estimates and
Forecasts in US$ Million by Therapeutic Class: 2018 to 2025
Table 80: Spanish Psoriasis Drugs Historic Market Review by
Therapeutic Class in US$ Million: 2009-2017
Table 81: Psoriasis Drugs Market in Spain: Percentage Share
Breakdown of Sales by Therapeutic Class for 2009, 2019, and
2025
Table 82: Spanish Psoriasis Drugs Market Estimates and
Forecasts in US$ Million by Treatment: 2018 to 2025
Table 83: Spanish Psoriasis Drugs Historic Market Review by
Treatment in US$ Million: 2009-2017
Table 84: Psoriasis Drugs Market in Spain: Percentage Share
Breakdown of Sales by Treatment for 2009, 2019, and 2025
RUSSIA
Table 85: Russian Psoriasis Drugs Market Estimates and
Projections in US$ Million by Therapeutic Class: 2018 to 2025
Table 86: Psoriasis Drugs Market in Russia by Therapeutic
Class: A Historic Review in US$ Million for 2009-2017
Table 87: Russian Psoriasis Drugs Market Share Breakdown by
Therapeutic Class: 2009 VS 2019 VS 2025
Table 88: Russian Psoriasis Drugs Market Estimates and
Projections in US$ Million by Treatment: 2018 to 2025
Table 89: Psoriasis Drugs Market in Russia by Treatment: A
Historic Review in US$ Million for 2009-2017
Table 90: Russian Psoriasis Drugs Market Share Breakdown by
Treatment: 2009 VS 2019 VS 2025
REST OF EUROPE
Table 91: Rest of Europe Psoriasis Drugs Market Estimates and
Forecasts in US$ Million by Therapeutic Class: 2018-2025
Table 92: Psoriasis Drugs Market in Rest of Europe in US$
Million by Therapeutic Class: A Historic Review for the Period
2009-2017
Table 93: Rest of Europe Psoriasis Drugs Market Share Breakdown
by Therapeutic Class: 2009 VS 2019 VS 2025
Table 94: Rest of Europe Psoriasis Drugs Market Estimates and
Forecasts in US$ Million by Treatment: 2018-2025
Table 95: Psoriasis Drugs Market in Rest of Europe in US$
Million by Treatment: A Historic Review for the Period
2009-2017
Table 96: Rest of Europe Psoriasis Drugs Market Share Breakdown
by Treatment: 2009 VS 2019 VS 2025
ASIA-PACIFIC
Table 97: Asia-Pacific Psoriasis Drugs Market Estimates and
Forecasts in US$ Million by Region/Country: 2018-2025
Table 98: Psoriasis Drugs Market in Asia-Pacific: Historic
Market Analysis in US$ Million by Region/Country for the Period
2009-2017
Table 99: Asia-Pacific Psoriasis Drugs Market Share Analysis by
Region/Country: 2009 VS 2019 VS 2025
Table 100: Psoriasis Drugs Market in Asia-Pacific by
Therapeutic Class: Estimates and Projections in US$ Million for
the Period 2018-2025
Table 101: Asia-Pacific Psoriasis Drugs Historic Market
Scenario in US$ Million by Therapeutic Class: 2009-2017
Table 102: Asia-Pacific Psoriasis Drugs Market Share Analysis
by Therapeutic Class: 2009 VS 2019 VS 2025
Table 103: Psoriasis Drugs Market in Asia-Pacific by Treatment:
Estimates and Projections in US$ Million for the Period
2018-2025
Table 104: Asia-Pacific Psoriasis Drugs Historic Market
Scenario in US$ Million by Treatment: 2009-2017
Table 105: Asia-Pacific Psoriasis Drugs Market Share Analysis
by Treatment: 2009 VS 2019 VS 2025
AUSTRALIA
Table 106: Psoriasis Drugs Market in Australia: Recent Past,
Current and Future Analysis in US$ Million by Therapeutic Class
for the Period 2018-2025
Table 107: Australian Psoriasis Drugs Historic Market Analysis
in US$ Million by Therapeutic Class: 2009-2017
Table 108: Australian Psoriasis Drugs Market Share Breakdown by
Therapeutic Class: 2009 VS 2019 VS 2025
Table 109: Psoriasis Drugs Market in Australia: Recent Past,
Current and Future Analysis in US$ Million by Treatment for the
Period 2018-2025
Table 110: Australian Psoriasis Drugs Historic Market Analysis
in US$ Million by Treatment: 2009-2017
Table 111: Australian Psoriasis Drugs Market Share Breakdown by
Treatment: 2009 VS 2019 VS 2025
INDIA
Table 112: Indian Psoriasis Drugs Market Estimates and
Forecasts in US$ Million by Therapeutic Class: 2018 to 2025
Table 113: Indian Psoriasis Drugs Historic Market Review by
Therapeutic Class in US$ Million: 2009-2017
Table 114: Psoriasis Drugs Market in India: Percentage Share
Breakdown of Sales by Therapeutic Class for 2009, 2019, and
2025
Table 115: Indian Psoriasis Drugs Market Estimates and
Forecasts in US$ Million by Treatment: 2018 to 2025
Table 116: Indian Psoriasis Drugs Historic Market Review by
Treatment in US$ Million: 2009-2017
Table 117: Psoriasis Drugs Market in India: Percentage Share
Breakdown of Sales by Treatment for 2009, 2019, and 2025
SOUTH KOREA
Table 118: Psoriasis Drugs Market in South Korea: Recent Past,
Current and Future Analysis in US$ Million by Therapeutic Class
for the Period 2018-2025
Table 119: South Korean Psoriasis Drugs Historic Market
Analysis in US$ Million by Therapeutic Class: 2009-2017
Table 120: Psoriasis Drugs Market Share Distribution in South
Korea by Therapeutic Class: 2009 VS 2019 VS 2025
Table 121: Psoriasis Drugs Market in South Korea: Recent Past,
Current and Future Analysis in US$ Million by Treatment for the
Period 2018-2025
Table 122: South Korean Psoriasis Drugs Historic Market
Analysis in US$ Million by Treatment: 2009-2017
Table 123: Psoriasis Drugs Market Share Distribution in South
Korea by Treatment: 2009 VS 2019 VS 2025
REST OF ASIA-PACIFIC
Table 124: Rest of Asia-Pacific Market for Psoriasis Drugs:
Annual Sales Estimates and Projections in US$ Million by
Therapeutic Class for the Period 2018-2025
Table 125: Psoriasis Drugs Market in Rest of Asia-Pacific:
Historic Sales Analysis in US$ Million by Therapeutic Class for
the Period 2009-2017
Table 126: Rest of Asia-Pacific Psoriasis Drugs Market Share
Analysis by Therapeutic Class: 2009 VS 2019 VS 2025
Table 127: Rest of Asia-Pacific Market for Psoriasis Drugs:
Annual Sales Estimates and Projections in US$ Million by
Treatment for the Period 2018-2025
Table 128: Psoriasis Drugs Market in Rest of Asia-Pacific:
Historic Sales Analysis in US$ Million by Treatment for the
Period 2009-2017
Table 129: Rest of Asia-Pacific Psoriasis Drugs Market Share
Analysis by Treatment: 2009 VS 2019 VS 2025
LATIN AMERICA
Table 130: Latin American Psoriasis Drugs Market Trends by
Region/Country in US$ Million: 2018-2025
Table 131: Psoriasis Drugs Market in Latin America in US$
Million by Region/Country: A Historic Perspective for the
Period 2009-2017
Table 132: Latin American Psoriasis Drugs Market Percentage
Breakdown of Sales by Region/Country: 2009, 2019, and 2025
Table 133: Latin American Psoriasis Drugs Market Growth
Prospects in US$ Million by Therapeutic Class for the Period
2018-2025
Table 134: Psoriasis Drugs Historic Market Analysis in Latin
America in US$ Million by Therapeutic Class: 2009-2017
Table 135: Latin American Psoriasis Drugs Market by
Therapeutic Class: Percentage Breakdown of Sales for 2009,
2019, and 2025
Table 136: Latin American Psoriasis Drugs Market Growth
Prospects in US$ Million by Treatment for the Period 2018-2025
Table 137: Psoriasis Drugs Historic Market Analysis in Latin
America in US$ Million by Treatment: 2009-2017
Table 138: Latin American Psoriasis Drugs Market by Treatment:
Percentage Breakdown of Sales for 2009, 2019, and 2025
ARGENTINA
Table 139: Argentinean Psoriasis Drugs Market Estimates and
Forecasts in US$ Million by Therapeutic Class: 2018-2025
Table 140: Psoriasis Drugs Market in Argentina in US$ Million
by Therapeutic Class: A Historic Review for the Period
2009-2017
Table 141: Argentinean Psoriasis Drugs Market Share Breakdown
by Therapeutic Class: 2009 VS 2019 VS 2025
Table 142: Argentinean Psoriasis Drugs Market Estimates and
Forecasts in US$ Million by Treatment: 2018-2025
Table 143: Psoriasis Drugs Market in Argentina in US$ Million
by Treatment: A Historic Review for the Period 2009-2017
Table 144: Argentinean Psoriasis Drugs Market Share Breakdown
by Treatment: 2009 VS 2019 VS 2025
BRAZIL
Table 145: Psoriasis Drugs Market in Brazil by Therapeutic
Class: Estimates and Projections in US$ Million for the Period
2018-2025
Table 146: Brazilian Psoriasis Drugs Historic Market Scenario
in US$ Million by Therapeutic Class: 2009-2017
Table 147: Brazilian Psoriasis Drugs Market Share Analysis by
Therapeutic Class: 2009 VS 2019 VS 2025
Table 148: Psoriasis Drugs Market in Brazil by Treatment:
Estimates and Projections in US$ Million for the Period
2018-2025
Table 149: Brazilian Psoriasis Drugs Historic Market Scenario
in US$ Million by Treatment: 2009-2017
Table 150: Brazilian Psoriasis Drugs Market Share Analysis by
Treatment: 2009 VS 2019 VS 2025
MEXICO
Table 151: Psoriasis Drugs Market in Mexico: Recent Past,
Current and Future Analysis in US$ Million by Therapeutic Class
for the Period 2018-2025
Table 152: Mexican Psoriasis Drugs Historic Market Analysis in
US$ Million by Therapeutic Class: 2009-2017
Table 153: Mexican Psoriasis Drugs Market Share Breakdown by
Therapeutic Class: 2009 VS 2019 VS 2025
Table 154: Psoriasis Drugs Market in Mexico: Recent Past,
Current and Future Analysis in US$ Million by Treatment for the
Period 2018-2025
Table 155: Mexican Psoriasis Drugs Historic Market Analysis in
US$ Million by Treatment: 2009-2017
Table 156: Mexican Psoriasis Drugs Market Share Breakdown by
Treatment: 2009 VS 2019 VS 2025
REST OF LATIN AMERICA
Table 157: Rest of Latin America Psoriasis Drugs Market
Estimates and Projections in US$ Million by Therapeutic Class:
2018 to 2025
Table 158: Psoriasis Drugs Market in Rest of Latin America by
Therapeutic Class: A Historic Review in US$ Million for
2009-2017
Table 159: Rest of Latin America Psoriasis Drugs Market Share
Breakdown by Therapeutic Class: 2009 VS 2019 VS 2025
Table 160: Rest of Latin America Psoriasis Drugs Market
Estimates and Projections in US$ Million by Treatment: 2018 to
2025
Table 161: Psoriasis Drugs Market in Rest of Latin America by
Treatment: A Historic Review in US$ Million for 2009-2017
Table 162: Rest of Latin America Psoriasis Drugs Market Share
Breakdown by Treatment: 2009 VS 2019 VS 2025
MIDDLE EAST
Table 163: The Middle East Psoriasis Drugs Market Estimates and
Forecasts in US$ Million by Region/Country: 2018-2025
Table 164: Psoriasis Drugs Market in the Middle East by
Region/Country in US$ Million: 2009-2017
Table 165: The Middle East Psoriasis Drugs Market Share
Breakdown by Region/Country: 2009, 2019, and 2025
Table 166: The Middle East Psoriasis Drugs Market Estimates and
Forecasts in US$ Million by Therapeutic Class: 2018 to 2025
Table 167: The Middle East Psoriasis Drugs Historic Market by
Therapeutic Class in US$ Million: 2009-2017
Table 168: Psoriasis Drugs Market in the Middle East:
Percentage Share Breakdown of Sales by Therapeutic Class for
2009, 2019, and 2025
Table 169: The Middle East Psoriasis Drugs Market Estimates and
Forecasts in US$ Million by Treatment: 2018 to 2025
Table 170: The Middle East Psoriasis Drugs Historic Market by
Treatment in US$ Million: 2009-2017
Table 171: Psoriasis Drugs Market in the Middle East:
Percentage Share Breakdown of Sales by Treatment for 2009,
2019, and 2025
IRAN
Table 172: Iranian Market for Psoriasis Drugs: Annual Sales
Estimates and Projections in US$ Million by Therapeutic Class
for the Period 2018-2025
Table 173: Psoriasis Drugs Market in Iran: Historic Sales
Analysis in US$ Million by Therapeutic Class for the Period
2009-2017
Table 174: Iranian Psoriasis Drugs Market Share Analysis by
Therapeutic Class: 2009 VS 2019 VS 2025
Table 175: Iranian Market for Psoriasis Drugs: Annual Sales
Estimates and Projections in US$ Million by Treatment for the
Period 2018-2025
Table 176: Psoriasis Drugs Market in Iran: Historic Sales
Analysis in US$ Million by Treatment for the Period 2009-2017
Table 177: Iranian Psoriasis Drugs Market Share Analysis by
Treatment: 2009 VS 2019 VS 2025
ISRAEL
Table 178: Israeli Psoriasis Drugs Market Estimates and
Forecasts in US$ Million by Therapeutic Class: 2018-2025
Table 179: Psoriasis Drugs Market in Israel in US$ Million by
Therapeutic Class: A Historic Review for the Period 2009-2017
Table 180: Israeli Psoriasis Drugs Market Share Breakdown by
Therapeutic Class: 2009 VS 2019 VS 2025
Table 181: Israeli Psoriasis Drugs Market Estimates and
Forecasts in US$ Million by Treatment: 2018-2025
Table 182: Psoriasis Drugs Market in Israel in US$ Million by
Treatment: A Historic Review for the Period 2009-2017
Table 183: Israeli Psoriasis Drugs Market Share Breakdown by
Treatment: 2009 VS 2019 VS 2025
SAUDI ARABIA
Table 184: Saudi Arabian Psoriasis Drugs Market Growth
Prospects in US$ Million by Therapeutic Class for the Period
2018-2025
Table 185: Psoriasis Drugs Historic Market Analysis in Saudi
Arabia in US$ Million by Therapeutic Class: 2009-2017
Table 186: Saudi Arabian Psoriasis Drugs Market by Therapeutic
Class: Percentage Breakdown of Sales for 2009, 2019, and 2025
Table 187: Saudi Arabian Psoriasis Drugs Market Growth
Prospects in US$ Million by Treatment for the Period 2018-2025
Table 188: Psoriasis Drugs Historic Market Analysis in Saudi
Arabia in US$ Million by Treatment: 2009-2017
Table 189: Saudi Arabian Psoriasis Drugs Market by Treatment:
Percentage Breakdown of Sales for 2009, 2019, and 2025
UNITED ARAB EMIRATES
Table 190: Psoriasis Drugs Market in the United Arab Emirates:
Recent Past, Current and Future Analysis in US$ Million by
Therapeutic Class for the Period 2018-2025
Table 191: United Arab Emirates Psoriasis Drugs Historic Market
Analysis in US$ Million by Therapeutic Class: 2009-2017
Table 192: Psoriasis Drugs Market Share Distribution in United
Arab Emirates by Therapeutic Class: 2009 VS 2019 VS 2025
Table 193: Psoriasis Drugs Market in the United Arab Emirates:
Recent Past, Current and Future Analysis in US$ Million by
Treatment for the Period 2018-2025
Table 194: United Arab Emirates Psoriasis Drugs Historic Market
Analysis in US$ Million by Treatment: 2009-2017
Table 195: Psoriasis Drugs Market Share Distribution in United
Arab Emirates by Treatment: 2009 VS 2019 VS 2025
REST OF MIDDLE EAST
Table 196: Psoriasis Drugs Market in Rest of Middle East:
Recent Past, Current and Future Analysis in US$ Million by
Therapeutic Class for the Period 2018-2025
Table 197: Rest of Middle East Psoriasis Drugs Historic Market
Analysis in US$ Million by Therapeutic Class: 2009-2017
Table 198: Rest of Middle East Psoriasis Drugs Market Share
Breakdown by Therapeutic Class: 2009 VS 2019 VS 2025
Table 199: Psoriasis Drugs Market in Rest of Middle East:
Recent Past, Current and Future Analysis in US$ Million by
Treatment for the Period 2018-2025
Table 200: Rest of Middle East Psoriasis Drugs Historic Market
Analysis in US$ Million by Treatment: 2009-2017
Table 201: Rest of Middle East Psoriasis Drugs Market Share
Breakdown by Treatment: 2009 VS 2019 VS 2025
AFRICA
Table 202: African Psoriasis Drugs Market Estimates and
Projections in US$ Million by Therapeutic Class: 2018 to 2025
Table 203: Psoriasis Drugs Market in Africa by Therapeutic
Class: A Historic Review in US$ Million for 2009-2017
Table 204: African Psoriasis Drugs Market Share Breakdown by
Therapeutic Class: 2009 VS 2019 VS 2025
Table 205: African Psoriasis Drugs Market Estimates and
Projections in US$ Million by Treatment: 2018 to 2025
Table 206: Psoriasis Drugs Market in Africa by Treatment: A
Historic Review in US$ Million for 2009-2017
Table 207: African Psoriasis Drugs Market Share Breakdown by
Treatment: 2009 VS 2019 VS 2025

IV. COMPETITION

ABBVIE
AMGEN
CELGENE CORPORATION
ELI LILLY AND COMPANY
JOHNSON & JOHNSON
MERCK & CO., INC.
NOVARTIS INTERNATIONAL AG
UCB SA

V. CURATED RESEARCH
Read the full report: https://www.reportlinker.com/p05818016/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001